Latest Diabetes: Type II news
GLP-1 Receptor Agonist Use Linked to Lower Mortality in Seniors With Cancer, T2D
posted July 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
posted July 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
posted July 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
posted July 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk 
Nearly 1 in 10 Older Adults Used Cannabis in the Past Year 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Related Articles
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes Monthly Specialist Briefings
Stay Connected
